USANA Health Sciences, Inc.
NYSE:USNAPackaged Foods
+$0.71 today
- Market cap
- $244.42M
- Beta
- 0.77
- P/E (TTM)
- 39.6
- EPS (TTM)
- $0.48
Volume 0.15M
Average 0.12M
USNA Gross Margin
Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.
USANA Health Sciences, Inc.NYSE: USNA
Gross Margin · Q1 FY2026 · quarter ended Apr 2026
Gross margin widens to 76.2%
Gross margin was 76.2% in Q1 FY2026, up 0.6 pp from a year earlier. On a trailing-twelve-month basis it was 76.7%, down 1.6 pp year over year. Over 3 fiscal years it narrowed by 1.0 pp.
Context
- Gross margin widened in 1 of the last 3 fiscal years.
- FY2025 was the lowest level in the 4 fiscal years shown.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Margin history
Percent of revenue · from the income statement
- Latest · FY2025
- 78.3%
- Year-over-year change
- -1.1pp
| Period | Period end | Gross Margin | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 78.3% | -1.1pp |
| FY2024 | 2024-12-28 | 79.4% | -0.0pp |
| FY2023 | 2023-12-31 | 79.4% | +0.2pp |
| FY2022 | 2022-12-31 | 79.2% | -1.3pp |
| FY2021 | 2021-12-31 | 80.5% | — |
Gross Margin vs competitors
How USNA compares with its peers on the latest reported figures
- USNA's LTM Apr 2026 gross margin of 76.7% is the highest of the 8 companies compared; the peer median is 24.5%.
- Its year-over-year change of -1.6 pp is the 5th highest of 8, against a peer median of -1.4 pp.
- Over three fiscal years its change of -1.0 pp compares with a peer median of +1.7 pp.
| Company | Period | LTM level | YoY | 3-year change |
|---|---|---|---|---|
| LTM Apr 2026 | 76.7% | -1.6 pp | -1.0 pp | |
| LTM Mar 2026 | 33.9% | -5.6 pp | +1.7 pp | |
| LTM Mar 2026 | 28.6% | -1.4 pp | -1.7 pp | |
| LTM Mar 2026 | 28.5% | +3.1 pp | +8.5 pp | |
| LTM Apr 2026 | 24.5% | -0.6 pp | +4.2 pp | |
| LTM Mar 2026 | 24.1% | -23.6 pp | -19.9 pp | |
| LTM Apr 2026 | 20.5% | -0.7 pp | +2.0 pp | |
WESTWestrock Coffee Company, LLC | LTM Mar 2026 | 13.0% | -3.7 pp | -7.3 pp |
| Peer median (excluding USNA) | 24.5% | -1.4 pp | +1.7 pp | |
Competitors are the stored peer set for USNA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 1.19B | 998.6M | 921.01M | 854.5M | 925.26M |
| Cost of Revenue | 230.93M | 207.28M | 189.4M | 175.75M | 200.85M |
| Gross Profit | 955.53M | 791.32M | 731.62M | 678.75M | 724.41M |
| Gross Margin | 80.5% | 79.2% | 79.4% | 79.4% | 78.3% |
| Research & Development | 11.11M | 11.56M | 11.45M | 11.57M | 0 |
| Selling, General & Admin | 774.23M | 672.14M | 627.1M | 600.86M | 337.37M |
| Operating Expenses | 785.34M | 683.7M | 638.54M | 612.43M | 673.54M |
| Depreciation & Amortization | 22.19M | 21.41M | 20.4M | 22.23M | 39.7M |
| EBITDA | 192.89M | 130.22M | 123.11M | 98.86M | 82.07M |
| EBITDA Margin | 16.3% | 13.0% | 13.4% | 11.6% | 8.9% |
| Operating Income | 170.19M | 107.61M | 93.07M | 66.32M | 50.86M |
| Operating Margin | 14.3% | 10.8% | 10.1% | 7.8% | 5.5% |
| Interest Income | 2.52M | 3.79M | 9.64M | 11.32M | 2.42M |
| Interest Expense | 57K | 192K | 262K | 281K | 842K |
| Other Income / Expenses | 450K | 1.01M | 9.38M | 10.03M | (9.34M) |
| Income Before Tax | 170.64M | 108.62M | 102.45M | 76.35M | 41.53M |
| Pre-Tax Margin | 14.4% | 10.9% | 11.1% | 8.9% | 4.5% |
| Income Tax Expense | 54.14M | 39.27M | 38.67M | 34.29M | 30.05M |
| Net Income | 116.51M | 69.35M | 63.79M | 42.03M | 10.76M |
| Net Margin | 9.8% | 6.9% | 6.9% | 4.9% | 1.2% |
| EPS (Basic) | 5.78 | 3.60 | 3.33 | 2.20 | 0.58 |
| EPS (Diluted) | 5.73 | 3.59 | 3.30 | 2.19 | 0.58 |
| Weighted Avg Shares | 20.15M | 19.25M | 19.25M | 19.06M | 18.57M |
| Weighted Avg Shares (Diluted) | 20.34M | 19.31M | 19.35M | 19.16M | 18.57M |
USANA Health Sciences, Inc.
NYSE:USNA
Intrinsic Alpha fair value
Locked
Current Price
$13.22
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.